Pharma

Your Unread Messages

See All

Your Article Summary

See Latest Articles

Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine
Novartis, 11/06/09

Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell culture–based Influenza A(H1N1) 2009 monovalent vaccine, Celtura. Novartis continues to pursue registration in other major countries, including Japan and Switzerland.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

AstraZeneca submits US New Drug Application for ticagrelor, an investigational antiplatelet agent
AstraZeneca, 11/23/09

Dendreon Receives FDA Acknowledgement of Complete Response
Dendreon Coproration, 11/23/09

Astellas and XenoPort Announce Submission of a New Drug Application in Japan Requesting PMDA Approval of ASP8825/XP13512 for Restless Legs Syndrome
XenoPort, 11/23/09

 See all of Drug/Product Approvals

Today in Regulatory Issues...keeping you current

Receive free subspecialty "5-minute updates" via email

Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09

Leavitt Leaving CCHIT
HealthDataManagement, 11/20/09

AzHHAs Rivers to retire in 2011
American Hospital Association News, 11/16/09

 See all of Regulatory Issues